Background: The routine measurement of pleural fluid amylase is frequently
recommended, but the cost-effectiveness of this procedure is unknown.
Methods: To assess the utility of routine measurement of pleural fluid amyl
ase in evaluating pleural effusions, we measured amylase, glucose, lactate
dehydrogenase, and protein levels and blood cell counts in 379 patients und
ergoing thoracentesis during a 22-month period from 1997 to 1999. Of these,
199 had effusions after cardiac surgery; 61, malignant; 48, transudative;
28, parapneumonic; 2, chylous; 2, rheumatoid; 1, tuberculous: and 1, from c
hronic pleuritis. There were 37 exudates of unknown origin.
Results : Measurement of pleural fluid amylase levels did not assist in det
ermining the origin of the effusion in any of the patients. Amylase levels
greater than 100 U/L (normal serum level in our laboratory is 30-110 U/L) w
ere found in 5 (1.3%) of 379 patients: 1 patient with congestive heart fail
ure (amylase, 173 U/L), 2 with post-cardiac surgery effusions (144 U/L and
130 U/L), 1 with pneumonia (109 U/L), and 1 with lung cancer (105 U/L).
Conclusions: The routine measurement of pleural fluid amylase levels is nei
ther clinically indicated nor cost-effective. We suggest that pleural fluid
serum amylase levels be measured only if there is a pretest suspicion of a
cute pancreatitis, chronic pancreatic disease, or esophageal rupture.